Neoadjuvant therapy in rectal cancer

FJ Fleming, L Påhlman… - Diseases of the colon & …, 2011 - journals.lww.com
BACKGROUND: The optimal type of neoadjuvant therapy regimen in rectal cancer is
contentious. OBJECTIVE: This study aimed to review the impact of neoadjuvant therapy on …

Evidence and research in rectal cancer

V Valentini, R Beets-Tan, JM Borras… - Radiotherapy and …, 2008 - Elsevier
The main evidences of epidemiology, diagnostic imaging, pathology, surgery, radiotherapy,
chemotherapy and follow-up are reviewed to optimize the routine treatment of rectal cancer …

Circumferential resection margin as a prognostic factor in rectal cancer

TE Bernstein, BH Endreseth… - Journal of British …, 2009 - academic.oup.com
Background This study examined the prognostic impact of the circumferential resection
margin (CRM) in patients with rectal cancer treated by total mesorectal excision (TME) with …

Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993–2010

MG Guren, H Kørner, F Pfeffer, TÅ Myklebust… - Acta …, 2015 - Taylor & Francis
Background. The Norwegian Rectal Cancer Project was initated in 1993 with the aims of
improving surgery, decreasing local recurrence rates, improving survival, and establishing a …

[HTML][HTML] Prognostic importance of circumferential resection margin in the era of evolving surgical and multidisciplinary treatment of rectal cancer: A systematic review …

R Detering, MLW Rutgers, WA Bemelman, R Hompes… - Surgery, 2021 - Elsevier
Background Circumferential resection margin is considered an important prognostic
parameter after rectal cancer surgery, but its impact might have changed because of …

Use of preoperative magnetic resonance imaging to select patients with rectal cancer for neoadjuvant chemoradiation—interim analysis of the German OCUM Trial …

ME Kreis, R Ruppert, H Ptok, J Strassburg… - Journal of …, 2016 - Elsevier
Introduction Introduction of total mesorectal excision (TME) surgery for rectal cancer
decreased local recurrence dramatically. Additional neoadjuvant chemoradiation (nCR) is …

[HTML][HTML] Surgical treatment for rectal cancer: an international perspective on what the medical gastroenterologist needs to know

RO Lindsetmo, YG Joh, CP Delaney - World journal of …, 2008 - ncbi.nlm.nih.gov
Rectal cancer accounts for one third of all colorectal cancers. The age adjusted death rates
from colorectal cancer have declined over recent decades due to a combination of colorectal …

Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy

I Zlobec, T Vuong, CC Compton, A Lugli… - British journal of …, 2008 - nature.com
The ability to predict complete pathologic response or sensitivity to radiation before
treatment would have a significant impact on the selection of patients for preoperative …

[HTML][HTML] A meta-analysis assessing the survival implications of subclassifying T3 rectal tumours

MRS Siddiqui, C Simillis, J Bhoday, NJ Battersby… - European Journal of …, 2018 - Elsevier
Aim Although T3 tumour subclassifications have been linked to prognosis, its mandatory
adoption in histopathological reports has not been incorporated. This article focusses on the …

SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021)

J Capdevila, MA Gómez, M Guillot, D Páez… - Clinical and …, 2022 - Springer
The management of localized rectal cancer requires a multidisciplinary approach to optimize
outcomes, reduce morbidity and prevent under or overtreatments. While early stages may …